3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
3
Melanoma
2
Breast Neoplasms
2
Advanced Malignant Solid Neoplasm
2
Urinary Bladder Neoplasms
1
Syndrome
1
Spondylitis, Ankylosing
1
Rectal Neoplasms
1
Psoriasis
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Malignant Solid Neoplasm
1
Malignant Female Reproductive System Neoplasm
1
Lupus Erythematosus, Systemic
1
Kidney Neoplasms
1
Inflammatory Breast Neoplasms
1
Inflammatory Bowel Diseases
1
Hematopoietic and Lymphatic System Neoplasm
1
Hematologic Neoplasms
1
HIV Infections
1
Fatigue
1
Endometrial Neoplasms
1
Dyspnea
1
Disease
1
Crohn Disease
1
Cough
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Colitis, Ulcerative
1
Interventions
Dexamethasone
40
Lenalidomide
26
Bortezomib
21
daratumumab
20
pomalidomide
19
Cyclophosphamide
14
Specimen Handling
13
Biopsy
13
carfilzomib
12
talquetamab
9
Magnetic Resonance Spectroscopy
9
Calcium Dobesilate
9
isatuximab
8
Melphalan
8
iberdomide
7
fludarabine
7
belantamab mafodotin
6
X-Rays
5
selinexor
4
fludarabine phosphate
4
elotuzumab
4
Nuclear Medicine Department, Hospital
4
trametinib
3
tocilizumab
3
dexamethasone acetate
3
dexamethasone 21-phosphate
3
dabrafenib
3
auricularum
3
Whole-Body Irradiation
3
Thalidomide
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Multiple Myeloma
×
Educational Status
×
30 days
×
Clear all
No trials found.